# FDA Inspection 1011854 - NATCO Pharma Limited - January 24, 2017

Source: https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/6e9d6dc9-1872-4792-aa61-4d0ea396c351
Source feed: FDA_Inspections

> FDA Inspection 1011854 for NATCO Pharma Limited on January 24, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1011854
- Company Name: NATCO Pharma Limited
- Inspection Date: 2017-01-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1273711 - 2025-06-19](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/80aae95c-db8b-4043-b5c3-41597f602f4d)
- [FDA Inspection 1137171 - 2019-06-24](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/9c7b0cce-1acc-45b6-a00d-602bb1633ccd)
- [FDA Inspection 1095772 - 2019-06-06](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/ea855f48-56a5-4020-95b4-2e58b1a8caf2)
- [FDA Inspection 880454 - 2014-05-23](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/abd681f2-ce54-4551-8971-47c1474bc884)
- [FDA Inspection 762119 - 2011-11-18](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/57a12f0b-492e-4d21-af3a-fbf3b3e5ae79)

Company: https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c